Cardio-Nephrology Confluence of the Heart and Kidney in Clinical Practice
Extending from the outpatient management of cardiovascular and kidney disease, to hospital-based decision making in patients with cardio-renal disease and complex interfaces such as hemodialysis in patients with ventricular assist device support, this book serves as a single reference point for card...
| Other Authors: | , , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Cham
Springer International Publishing
2017, 2017
|
| Edition: | 1st ed. 2017 |
| Subjects: | |
| Online Access: | |
| Collection: | Springer eBooks 2005- - Collection details see MPG.ReNa |
Table of Contents:
- PART I: CARDIOVASCULAR DISEASE SPECTRUM IN CHRONIC KIDNEY DISEASE
- Chapter 1 Endothelial Dysfunction and Nitric Oxide: Albuminuria as a Central Marker
- Chapter 2 Vascular and Valvular Calcification in Chronic Kidney Disease: Pathogenesis and Clinical Outcomes
- Chapter 3 Sudden Cardiac Death in CKD and ESKD: Risk Factors, Mechanisms, and Therapeutic Strategies
- Chapter 4 Coronary Artery Disease in CKD: Traditional and Nontraditional Risk Factors, Diagnosis and Management
- Chapter 5 CKD Associated Cardiomyopathy: Molecular Mechanisms, Imaging Modalities, Disease Evolution and Interventions
- PART II: CHRONIC KIDNEY DISEASE AND CAD: TWO SIDES OF THE SAME COIN
- Chapter 6 CKD as CAD Equivalent: Inflammatory Milieu and Vascular Oxidative Stress
- Chapter 7 Phosphorus and Mortality: Do we have the Panacea?
- Chapter 8 Inhibition of the Renin Angiotensin System: How far have we come?
- Chapter 9 Vitamin D and its Role in CKD and CAD: A Novel Therapeutic Target
- Chapter 20 Screening Strategies for Coronary Artery Disease (CAD) in Candidates for Kidney Transplants
- Chapter 21 Cardiac Pre-Operative Evaluation as an Opportunity to Optimize Risk Factors in Kidney Transplant Candidates
- Chapter 22 Revascularization in Patients on the Renal Transplant List: When and What is Appropriate?
- Chapter 23 Pulmonary Hypertension in the Potential Kidney Transplant Recipient
- Chapter 24 Cardiac Surveillance whilst Listed for Renal Transplantation
- Chapter 25 Post Kidney Transplant Modification of Cardiovascular Risk
- Ch. 26 Cardiomyopathy in the Potential Kidney Transplant Candidate
- PART V: ANTICOAGULATION AND ANTIPLATELET THERAPY IN CKD
- Chapter 27 Anticoagulation in Patients with Atrial Fibrillation and Chronic Kidney Disease
- Chapter 28 Anticoagulation-Related Nephropathy: Tip of the Iceberg
- Chapter 29 Impact of Antiplatelet Therapy and Platelet Reactivity Testing on Cardiovascular Outcomes in Patients with Chronic Kidney Disease
- Chapter 10 Association ofCatalytic (Labile) Iron with Cardiovascular Morbidity and Mortality
- Chapter 11 Erythropoietin and its Cardiovascular Effects
- PART III: CARDIO-RENAL SYNDROME
- Chapter 12 Pathophysiology of the Cardio-Renal Syndromes Types 1–5: Updates from the Eleventh Consensus Conference of the Acute Dialysis Quality Initiative (ADQI)
- Chapter 13 Hemodynamic Cross Talk in Cardiorenal Syndrome: Era of Biomarkers
- Chapter 14 Kidney Attack: Is NGAL Set to Take the Stage with Troponins?
- Chapter 15 Ultrafiltration Therapy in Decompensated Heart Failure
- Chapter 16 Bioimpedance Vectorial Analyses in Cardio Renal Syndrome
- Chapter 17 Novel Therapies for Acute Decompensated Heart Failure
- Chapter 18 Kidney Injury in Patients with Ventricular Assist Devices
- Chapter 19 Palliation with Dual Burden of Heart and Kidney Failure: An Underutilized Strategy
- PART IV: CARDIAC EVALUATION OF THE RENAL TRANSPLANT CANDIDATE
- Chapter 39 Chronic Kidney Disease and BP Goals
- Chapter 40 Renal Artery Stenosis: Diagnosis and Management
- Chapter 41 Renal Denervation: Current Opinions and Practice
- PART VI: INTERVENTIONAL STRATEGIES IN CARDIOVASCULAR DISEASE IN CKD
- Chapter 30 Revascularization Strategies in Chronic Kidney Disease: Percutaneous Coronary Intervention vs. Coronary Artery Bypass Graft Surgery
- Chapter 31 Revascularization Strategies in CKD: Anti-Platelet Therapy, Stent Type, Timing, and Complications of PCI
- Chapter 32 Peripheral Arterial Disease in CKD: Disease Burden, Outcomes and Interventional Strategies
- Chapter 33 Contrast Induced Nephropathy
- Chapter 34 Acute Kidney Injury after Cardiac Surgery
- PART VII: THE CARDIORENOMETABOLIC SPECTRUM
- Chapter 35 Dyslipidemias in CKD and ESKD: Outcomes and Management
- Chapter 36 The Cardiac Impact of Atherosclerotic Renovascular Disease (ARVD)
- Chapter 37 Preeclampsia: A Mirror into Future Cardiovascular and Renal Health
- Chapter 38 Obstructive Sleep Apnea: A Unifying Link between Cardiovascular and Renal Disease
- PART VIII: DILEMMAS IN HYPERTENSION